Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in ALS
NCT00140452Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in amyotrophic lateral sclerosis (ALS), sponsored by Dartmouth Health. Started Feb 2005; status: completed.
02
Drugs
thalidomide
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00140452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140452.